Skip to content
DataLookout
Menu

SLNNCT06697054

Sentinel Lymph Node (SLN) Mapping With Charcoal Carbon Dye in Early Stage Cervical Cancer

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved at least 2 years later, enrollment reduced 17%.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from May 12, 2026 to Jun 2028 Show 6 more changesShow less
    • Enrollment reopened
    • Eligibility criteria revised
    • Enrollment reduced: 60 → 50 participants
    • Study completion pushed from Jun 12, 2026 to Aug 2028
    • Site details revised
    • Publications: details revised at 4 of 4 entries
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Detection rate of sentinel lymph node(s)
Timeframe: Two years
Specifity of sentinel lymph node mapping by carbon dye or ICG
Timeframe: Two years
Sensitivity of both tracers will be compared.
Timeframe: Two years

Arms and interventions

Two different tracers as a sentinel lymph node agent will be compared in early cervical cancerExperimental

Two different tracers, one charcoal carbon dye and other indocyanine used as sentinel lymph node agent will be compared in early cervical cancer in terms of detection rates, sensitivity, specificity, negative and positive predictive value. Both tracers will be used in the patient.

Diagnostic tests: Sentinel node biopsy with either ICG or carbon dye injection to cervix

Sites

1 site in 1 country

  • Istanbul University Med Fac Dept. of Obstet and Gynecol. Division of Gynecologic OncologyIstanbul, Turkey, Turkey (Türkiye)